Amgen Inc.: accounts_payable
| Value | {"amount": 1403000000, "concept": "us-gaap:AccountsPayableCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2022-03-31) |
| Status | current |
| Entity | Amgen Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/3770aeb2-2d39-4ce3-bb85-f1315742c77d
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0000318154-22-000021Retrieved: 2026-08-19T07:29:19.522005+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000318154/accounts-payable/2022-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/3770aeb2-2d39-4ce3-bb85-f1315742c77d
History
- no predecessors — first report